REPL Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
68.2M
-6.9%
73.3M
+2.0%
71.9M
-14.7%
84.3M
-6.8%
90.4M
R&D
49.3M
-5.8%
52.3M
-1.5%
53.1M
-8.2%
57.9M
+0.1%
57.8M
SG&A
19.0M
-9.7%
21.0M
+12.2%
18.7M
-29.1%
26.4M
-18.9%
32.6M
Operating Income
-68247000
+6.9%
-73338000
-2.0%
-71868000
+14.7%
-84291000
+6.8%
-90422000
EBITDA
-67310000
+7.2%
-72569000
-4.7%
-69305000
+18.6%
-85164000
+4.9%
-89549000
Net Income
-69766000
+4.7%
-73217000
-3.2%
-70930000
+14.6%
-83100000
+4.1%
-86693000
EPS (Basic)
$-0.72
+6.5%
$-0.77
+0.0%
$-0.77
+14.4%
$-0.90
+5.3%
$-0.95
EPS (Diluted)
$-0.72
+6.5%
$-0.77
+0.0%
$-0.77
+14.4%
$-0.90
+5.3%
$-0.95
Shares (Diluted)
96.9M
+1.3%
95.6M
+3.7%
92.2M
+0.3%
91.9M
+0.4%
91.5M
Replimune (REPL) โ€” Financials